Hormonal treatments for endometriosis primarily target ESR1, ESR2, or PGR and have the highest affinity for these receptors; however, due to the structural similarity of hormone receptors, off-target effects at other receptors are possible [32]. Here, NR4A1 is linked to endometriosis.